Modafinil has an effective elimination half-life of about 15 hours after multiple doses, according to current prescribing information. Pharmacokinetic studies have produced somewhat different estimates depending on the study design and population, so this figure should be understood as an approximate population value rather than an exact elimination time for every person.
Half-life does not mean that modafinil stops working or disappears from the body after 15 hours. It describes how long it takes for the drug concentration to decrease by approximately half during elimination.
Key Takeaways
- Modafinil’s effective elimination half-life is about 15 hours after repeated dosing.
- After one half-life, approximately 50% of the reference drug concentration remains, rather than none.
- Modafinil contains R- and S-enantiomers that are eliminated at different rates, with R-modafinil persisting considerably longer.
- Modafinil’s relatively long half-life matters for residual drug levels, repeated daily dosing, steady state and the timing of prescribed doses.
- Half-life is not the same as how long modafinil feels effective, when it reaches peak concentration or how long it can be detected by a laboratory test.
What Does a 15-Hour Modafinil Half-Life Mean?
Because drug elimination is approximately exponential, each elapsed half-life reduces the remaining concentration by half. Using 15 hours as an illustrative value, approximately 50% of the reference concentration would remain after 15 hours, 25% after 30 hours and 12.5% after 45 hours.
| Time | Half-lives elapsed | Approximate amount remaining |
|---|---|---|
| 15 hours | 1 | 50% |
| 30 hours | 2 | 25% |
| 45 hours | 3 | 12.5% |
| 60 hours | 4 | 6.25% |
These are theoretical values based on a 15-hour half-life; actual plasma concentrations vary between individuals.
Why Does Modafinil’s Half-Life Matter?
Modafinil’s relatively long half-life means that some of a dose can remain in the body many hours after it is taken.
Timing Can Matter for Sleep
The prescribing information recommends morning administration for narcolepsy or obstructive sleep apnoea and administration approximately one hour before a work shift for shift-work disorder.
A long elimination half-life means that modafinil does not suddenly disappear later in the day. People prescribed modafinil should follow their prescribed dosing schedule rather than using half-life calculations to change the timing or amount of a dose themselves.
Modafinil Accumulates With Repeated Daily Dosing
Because a daily dose may not be completely eliminated before the next dose is taken, repeated administration produces some accumulation until concentrations reach steady state, when drug exposure develops a relatively stable pattern across successive dosing intervals.
Current prescribing information states that apparent steady state for total modafinil and R-modafinil is reached after approximately 2 to 4 days of dosing. In a controlled study of healthy men receiving modafinil once daily, steady state was reached after approximately three daily doses (Wong et al., 1999b).
How Long Does Modafinil Stay in Your Body?
Using the common pharmacokinetic rule of thumb of approximately five half-lives, a 15-hour half-life corresponds to about 75 hours, or just over three days, at which point a simplified exponential model predicts that approximately 3.125% of the reference concentration remains.
Five half-lives should not be treated as a precise cutoff at which modafinil suddenly disappears. It is a pharmacokinetic approximation used to describe progressive elimination.
Is This the Same as How Long Modafinil Is Detectable?
No. Laboratory detection and pharmacokinetic elimination are different measurements.
Whether modafinil or its metabolites can be detected depends on the biological sample, the compound being measured, the sensitivity of the assay and the threshold used to define detection. A half-life calculation therefore cannot determine when a blood, urine or other laboratory test will become negative.
Why Is Modafinil’s Half-Life Usually Given as a Range?
Pharmacokinetic estimates vary somewhat by study: Wong et al. (1999a) reported elimination half-lives of approximately 11 to 14 hours after a single 200 mg dose, while Wong et al. (1999b) reported approximately 15 hours at steady state.
Robertson and Hellriegel (2003) described modafinil’s elimination half-life as approximately 12 to 15 hours, while current U.S. prescribing information gives an effective elimination half-life of about 15 hours after multiple doses.
Study population, dosing conditions and individual pharmacokinetics can contribute to these differences.
Do 200 mg and 400 mg of Modafinil Have Different Half-Lives?
Taking a larger dose does not simply produce a proportionally longer half-life.
Wong et al. (1999b) studied repeated doses ranging from 200 to 800 mg per day and reported dose- and time-independent pharmacokinetics over the studied range. Current prescribing information describes linear pharmacokinetics for the individual modafinil enantiomers during repeated once-daily dosing between 200 and 600 mg.
A larger dose can increase the amount of drug in the body and overall exposure, but taking twice the dose does not mean that modafinil takes twice as long to eliminate half of its concentration.
Why Do R-Modafinil and S-Modafinil Have Different Half-Lives?
Modafinil is a racemic compound, meaning it contains equal amounts of two mirror-image forms of the molecule: R-modafinil and S-modafinil.
The two enantiomers have markedly different pharmacokinetics: Darwish et al. (2010) reported an elimination half-life of approximately 15 hours for R-modafinil, compared with approximately 4 to 5 hours for S-modafinil. Earlier pharmacokinetic research similarly found that the shorter-lived enantiomer was eliminated about three times faster than the longer-lived form (Wong et al., 1999a, 1999b).
Because S-modafinil is eliminated more rapidly, current prescribing information states that approximately 90% of modafinil at steady-state trough concentration is R-modafinil and 10% is S-modafinil.
The longer persistence of R-modafinil therefore contributes substantially to the effective half-life observed after repeated dosing (Robertson & Hellriegel, 2003).
Do Liver Function, Kidney Function and Age Affect Modafinil Clearance?
Liver Impairment
According to the prescribing information, a pharmacokinetic study involving nine people with cirrhosis found that oral modafinil clearance was reduced by approximately 60%, while steady-state concentrations were approximately twice those observed in people without hepatic impairment.
The prescribing information recommends reducing the dosage in severe hepatic impairment.
Kidney Impairment
In a study involving a single 200 mg dose, severe chronic renal failure did not significantly alter the pharmacokinetics of parent modafinil. However, exposure to modafinil acid, an inactive metabolite, increased approximately ninefold, according to the prescribing information.
It is therefore inaccurate to assume that severe renal impairment necessarily causes the parent drug itself to have a dramatically longer half-life.
Age
In the single-dose study by Wong et al. (1999a), modafinil clearance decreased with age among the male participants studied. Current prescribing information also notes evidence suggesting that clearance may be reduced in older adults, although concomitant medications and other factors can complicate interpretation.
The available evidence does not establish a separate fixed modafinil half-life for older adults.
How Is Modafinil Eliminated?
Modafinil is primarily eliminated through metabolism rather than excretion of large amounts of unchanged drug. Robertson and Hellriegel (2003) reported that less than 10% of a dose is excreted unchanged, with metabolites subsequently eliminated predominantly in urine.
Modafinil acid is the principal metabolite. In the single-dose study by Wong et al. (1999a), approximately 35% to 60% of the administered dose was recovered as modafinil acid.
Modafinil sulfone is another metabolite that reaches measurable plasma concentrations. Current prescribing information states that modafinil acid and modafinil sulfone do not appear to contribute to modafinil’s central nervous system-activating effects.
Is Modafinil’s Half-Life the Same as How Long It Works?
No. Elimination half-life is a pharmacokinetic measurement describing how quickly drug concentration declines, whereas the duration and intensity of wake-promoting effects are pharmacodynamic outcomes.
Someone should therefore not expect modafinil to feel equally strong for 15 hours simply because its effective elimination half-life is about 15 hours. Likewise, no longer noticing its wake-promoting effects does not mean that the drug has been completely eliminated.
Is Half-Life the Same as Modafinil’s Peak Concentration?
No. Modafinil generally reaches its peak plasma concentration approximately 2 to 4 hours after oral administration, whereas elimination occurs much more slowly (Robertson & Hellriegel, 2003).
The time to maximum concentration, or Tmax, describes when plasma levels reach their measured peak. Elimination half-life describes the rate at which drug concentration subsequently declines.
Does Food Change Modafinil’s Half-Life?
According to the prescribing information, taking modafinil with food can delay Tmax by approximately one hour without affecting overall bioavailability.
Frequently Asked Questions
How Much Modafinil Is Left After 24 Hours?
Assuming a 15-hour half-life, approximately 33% of the reference concentration would remain after 24 hours. Using a 12-hour half-life, approximately 25% would remain.
Is Modafinil’s Half-Life the Same for Everyone?
No. The published figures are population estimates, and pharmacokinetic studies have reported different values depending on factors such as study population and dosing conditions. Age and severe hepatic impairment can also affect modafinil clearance.
Does Modafinil Have a Longer Half-Life Than Armodafinil?
Modafinil contains both R-modafinil and S-modafinil, whereas armodafinil consists of the longer-lived R-enantiomer. The R-enantiomer has an elimination half-life of approximately 15 hours, while S-modafinil is eliminated more rapidly (Darwish et al., 2010).
References
Darwish, M., Kirby, M., D’Andrea, D. M., Yang, R., Hellriegel, E. T., & Robertson, P., Jr. (2010). Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: A randomized, open-label, crossover study. Clinical Therapeutics, 32(12), 2074–2087. https://doi.org/10.1016/j.clinthera.2010.11.009
DailyMed. (n.d.). Modafinil tablets: Prescribing information. U.S. National Library of Medicine.
Robertson, P., Jr., & Hellriegel, E. T. (2003). Clinical pharmacokinetic profile of modafinil. Clinical Pharmacokinetics, 42(2), 123–137. https://doi.org/10.2165/00003088-200342020-00002
Wong, Y. N., King, S. P., Simcoe, D., Gorman, S., Laughton, W., McCormick, G. C., & Grebow, P. E. (1999a). Open-label, single-dose pharmacokinetic study of modafinil tablets: Influence of age and gender in normal subjects. Journal of Clinical Pharmacology, 39(3), 281–288. https://doi.org/10.1177/009127009903900312
Wong, Y. N., Simcoe, D., Hartman, L. N., Laughton, W. B., King, S. P., McCormick, G. C., & Grebow, P. E. (1999b). A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. Journal of Clinical Pharmacology, 39(1), 30–40. https://doi.org/10.1177/00912709922007534